These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

460 related items for PubMed ID: 21135023

  • 1. Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course.
    Khademi M, Kockum I, Andersson ML, Iacobaeus E, Brundin L, Sellebjerg F, Hillert J, Piehl F, Olsson T.
    Mult Scler; 2011 Mar; 17(3):335-43. PubMed ID: 21135023
    [Abstract] [Full Text] [Related]

  • 2. Primary progressive versus relapsing-onset multiple sclerosis: presence and prognostic value of cerebrospinal fluid oligoclonal IgM.
    Sola P, Mandrioli J, Simone AM, Ferraro D, Bedin R, Annecca R, Venneri MG, Nichelli PF, Merelli E.
    Mult Scler; 2011 Mar; 17(3):303-11. PubMed ID: 21078694
    [Abstract] [Full Text] [Related]

  • 3. Osteopontin concentrations are increased in cerebrospinal fluid during attacks of multiple sclerosis.
    Börnsen L, Khademi M, Olsson T, Sørensen PS, Sellebjerg F.
    Mult Scler; 2011 Jan; 17(1):32-42. PubMed ID: 20921238
    [Abstract] [Full Text] [Related]

  • 4. Cannabinoids and B cells: emerging targets for treating progressive multiple sclerosis.
    Giovannoni G.
    Mult Scler; 2011 Mar; 17(3):259-61. PubMed ID: 21362756
    [No Abstract] [Full Text] [Related]

  • 5. Intrathecal IgM synthesis in pediatric MS is not a negative prognostic marker of disease progression: quantitative versus qualitative IgM analysis.
    Stauch C, Reiber H, Rauchenzauner M, Strasak A, Pohl D, Hanefeld F, Gärtner J, Rostásy KM.
    Mult Scler; 2011 Mar; 17(3):327-34. PubMed ID: 21123302
    [Abstract] [Full Text] [Related]

  • 6. Cerebrospinal fluid levels of CXCL13 are elevated in neuromyelitis optica.
    Zhong X, Wang H, Dai Y, Wu A, Bao J, Xu W, Cheng C, Lu Z, Qiu W, Hu X.
    J Neuroimmunol; 2011 Dec 15; 240-241():104-8. PubMed ID: 22036953
    [Abstract] [Full Text] [Related]

  • 7. Multiple sclerosis: BAFF and CXCL13 in cerebrospinal fluid.
    Ragheb S, Li Y, Simon K, VanHaerents S, Galimberti D, De Riz M, Fenoglio C, Scarpini E, Lisak R.
    Mult Scler; 2011 Jul 15; 17(7):819-29. PubMed ID: 21372118
    [Abstract] [Full Text] [Related]

  • 8. Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosis.
    Avsar T, Korkmaz D, Tütüncü M, Demirci NO, Saip S, Kamasak M, Siva A, Turanli ET.
    Mult Scler; 2012 Aug 15; 18(8):1081-91. PubMed ID: 22252467
    [Abstract] [Full Text] [Related]

  • 9. Neurofilament light as a prognostic marker in multiple sclerosis.
    Salzer J, Svenningsson A, Sundström P.
    Mult Scler; 2010 Mar 15; 16(3):287-92. PubMed ID: 20086018
    [Abstract] [Full Text] [Related]

  • 10. Increased plasma 8,12-iso-iPF2alpha- VI levels in relapsing multiple sclerosis patients are not predictive of disease progression.
    Teunissen CE, Sombekke M, van Winsen L, Killestein J, Barkhof F, Polman CH, Dijkstra CD, Blankenstein MA, Pratico D.
    Mult Scler; 2012 Aug 15; 18(8):1092-8. PubMed ID: 22695538
    [Abstract] [Full Text] [Related]

  • 11. Primary progressive multiple sclerosis diagnostic criteria: a reappraisal.
    Montalban X, Sastre-Garriga J, Filippi M, Khaleeli Z, Téllez N, Vellinga MM, Tur C, Brochet B, Barkhof F, Rovaris M, Miller DH, Polman CH, Rovira A, Thompson AJ.
    Mult Scler; 2009 Dec 15; 15(12):1459-65. PubMed ID: 19995843
    [Abstract] [Full Text] [Related]

  • 12. Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis.
    Thangarajh M, Gomez-Rial J, Hedström AK, Hillert J, Alvarez-Cermeño JC, Masterman T, Villar LM.
    Mult Scler; 2008 Nov 15; 14(9):1208-13. PubMed ID: 18755821
    [Abstract] [Full Text] [Related]

  • 13. Absence of cerebrospinal fluid oligoclonal bands is associated with delayed disability progression in relapsing-remitting MS patients treated with interferon-beta.
    Annunziata P, Giorgio A, De Santi L, Zipoli V, Portaccio E, Amato MP, Clerici R, Scarpini E, Moscato G, Iudice A, Vacca G, Orefice G, Morra VB, Maimone D.
    J Neurol Sci; 2006 May 15; 244(1-2):97-102. PubMed ID: 16473370
    [Abstract] [Full Text] [Related]

  • 14. Oligoclonal bands and cerebrospinal fluid markers in multiple sclerosis: associations with disease course and progression.
    Lourenco P, Shirani A, Saeedi J, Oger J, Schreiber WE, Tremlett H.
    Mult Scler; 2013 Apr 15; 19(5):577-84. PubMed ID: 22961214
    [Abstract] [Full Text] [Related]

  • 15. Cerebrospinal fluid CXCL13 in clinically isolated syndrome patients: Association with oligoclonal IgM bands and prediction of Multiple Sclerosis diagnosis.
    Ferraro D, Galli V, Vitetta F, Simone AM, Bedin R, Del Giovane C, Morselli F, Filippini MM, Nichelli PF, Sola P.
    J Neuroimmunol; 2015 Jun 15; 283():64-9. PubMed ID: 26004159
    [Abstract] [Full Text] [Related]

  • 16. Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis.
    Kuhle J, Leppert D, Petzold A, Regeniter A, Schindler C, Mehling M, Anthony DC, Kappos L, Lindberg RL.
    Neurology; 2011 Apr 05; 76(14):1206-13. PubMed ID: 21346223
    [Abstract] [Full Text] [Related]

  • 17. Increasing incidence of multiple sclerosis in women in Northern Finland.
    Krökki O, Bloigu R, Reunanen M, Remes AM.
    Mult Scler; 2011 Feb 05; 17(2):133-8. PubMed ID: 20935028
    [Abstract] [Full Text] [Related]

  • 18. Increased cerebrospinal fluid chitotriosidase index in patients with multiple sclerosis.
    Verbeek MM, Notting EA, Faas B, Claessens-Linskens R, Jongen PJ.
    Acta Neurol Scand; 2010 May 05; 121(5):309-14. PubMed ID: 19925532
    [Abstract] [Full Text] [Related]

  • 19. Intrathecal IgM synthesis is a prognostic factor in multiple sclerosis.
    Villar LM, Masjuan J, González-Porqué P, Plaza J, Sádaba MC, Roldán E, Bootello A, Alvarez-Cermeño JC.
    Ann Neurol; 2003 Feb 05; 53(2):222-6. PubMed ID: 12557289
    [Abstract] [Full Text] [Related]

  • 20. CSF proteome analysis in clinically isolated syndrome (CIS): candidate markers for conversion to definite multiple sclerosis.
    Tumani H, Lehmensiek V, Rau D, Guttmann I, Tauscher G, Mogel H, Palm C, Hirt V, Suessmuth SD, Sapunova-Meier I, Ludolph AC, Brettschneider J.
    Neurosci Lett; 2009 Mar 13; 452(2):214-7. PubMed ID: 19383442
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.